• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Early Switch From Vancomycin to Daptomycin in Methicillin-Resistant Staphylococcus aureus Bacteremia: Still More Questions Than Answers.耐甲氧西林金黄色葡萄球菌血症中从万古霉素早期转换为达托霉素：问题仍多于答案。
Clin Infect Dis. 2021 Sep 15;73(6):1128-1129. doi: 10.1093/cid/ciab248.
2
Early high-dose daptomycin for methicillin-resistant Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentrations: ready for prime time?早期大剂量达托霉素用于万古霉素最低抑菌浓度升高的耐甲氧西林金黄色葡萄球菌血流感染：是时候广泛应用了吗？
Clin Infect Dis. 2013 Jun;56(11):1570-2. doi: 10.1093/cid/cit118. Epub 2013 Feb 28.
3
Duration of prior vancomycin therapy and subsequent daptomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia.耐甲氧西林金黄色葡萄球菌血症患者先前万古霉素治疗的持续时间及随后达托霉素的治疗结果
Diagn Microbiol Infect Dis. 2015 Oct;83(2):193-7. doi: 10.1016/j.diagmicrobio.2015.06.003. Epub 2015 Jun 11.
4
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.耐甲氧西林金黄色葡萄球菌引起的菌血症：新治疗方法的最新进展。
Infect Dis Clin North Am. 2020 Dec;34(4):849-861. doi: 10.1016/j.idc.2020.04.003. Epub 2020 Sep 30.
5
Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.早期使用达托霉素与万古霉素治疗万古霉素最低抑菌浓度（MIC）＞1mg/L 的耐甲氧西林金黄色葡萄球菌菌血症：一项匹配队列研究。
Clin Infect Dis. 2013 Jun;56(11):1562-9. doi: 10.1093/cid/cit112. Epub 2013 Feb 28.
6
Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.一名患有耐甲氧西林金黄色葡萄球菌菌血症的青少年使用达托霉素治疗失败。
Pediatr Infect Dis J. 2009 May;28(5):445-7. doi: 10.1097/INF.0b013e3181927891.
7
Probable Immortal Time Bias in Comparison of Daptomycin and Vancomycin for Methicillin-resistant Staphylococcus Aureus Bloodstream Infections.
Clin Infect Dis. 2021 Sep 15;73(6):1127-1128. doi: 10.1093/cid/ciab247.
8
Successful Use of High-dose Daptomycin in a Child With Staphylococcus aureus Endocarditis.高剂量达托霉素成功用于一名患金黄色葡萄球菌性心内膜炎的儿童。
Pediatr Infect Dis J. 2016 May;35(5):517-8. doi: 10.1097/INF.0000000000000958.
9
The efficacy of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bloodstream infection in patients with impaired renal function.达托霉素与万古霉素治疗肾功能受损患者耐甲氧西林金黄色葡萄球菌血流感染的疗效比较
Clin Infect Dis. 2014 Jun;58(11):1533-9. doi: 10.1093/cid/ciu165. Epub 2014 Mar 18.
10
High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus.万古霉素和达托霉素的高最低抑菌浓度以及耐甲氧西林金黄色葡萄球菌引起的复杂导管相关血流感染
Emerg Infect Dis. 2016 Jun;22(6):1057-66. doi: 10.3201/eid2206.151709.

本文引用的文献

1
Immortal Time Bias in Observational Studies.观察性研究中的不朽时间偏倚
JAMA. 2021 Feb 16;325(7):686-687. doi: 10.1001/jama.2020.9151.
2
Comparative Effectiveness of Switching to Daptomycin Versus Remaining on Vancomycin Among Patients With Methicillin-resistant Staphylococcus aureus (MRSA) Bloodstream Infections.比较耐甲氧西林金黄色葡萄球菌（MRSA）血流感染患者换用达托霉素与继续使用万古霉素的疗效。
Clin Infect Dis. 2021 Jan 29;72(Suppl 1):S68-S73. doi: 10.1093/cid/ciaa1572.
3
Clinical outcomes after initial treatment of methicillin-resistant infections.耐甲氧西林感染初始治疗后的临床结局。
Infect Drug Resist. 2018 Aug 6;11:1073-1081. doi: 10.2147/IDR.S159447. eCollection 2018.
4
Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.在一项针对耐甲氧西林金黄色葡萄球菌血流感染的倾向性匹配分析中，无论万古霉素最低抑菌浓度如何，达托霉素均可改善治疗结果。
Antimicrob Agents Chemother. 2016 Sep 23;60(10):5841-8. doi: 10.1128/AAC.00227-16. Print 2016 Oct.
5
Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.早期使用达托霉素与万古霉素治疗万古霉素最低抑菌浓度（MIC）＞1mg/L 的耐甲氧西林金黄色葡萄球菌菌血症：一项匹配队列研究。
Clin Infect Dis. 2013 Jun;56(11):1562-9. doi: 10.1093/cid/cit112. Epub 2013 Feb 28.
6
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.成人患者万古霉素的治疗监测：美国卫生系统药师协会、美国传染病学会和传染病药师协会的共识综述
Am J Health Syst Pharm. 2009 Jan 1;66(1):82-98. doi: 10.2146/ajhp080434.
7
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.达托霉素与标准疗法治疗金黄色葡萄球菌引起的菌血症和心内膜炎的比较。
N Engl J Med. 2006 Aug 17;355(7):653-65. doi: 10.1056/NEJMoa053783.

Early Switch From Vancomycin to Daptomycin in Methicillin-Resistant Staphylococcus aureus Bacteremia: Still More Questions Than Answers.

作者信息

Avedissian Sean N, Scheetz Marc H, Cortés-Penfield Nicolás

机构信息

Antiviral Pharmacology Laboratory, University of Nebraska Medical Center's Center for Drug Discovery, University of Nebraska Medical Center, Omaha, Nebraska, USA.

University of Nebraska Medical Center, College of Pharmacy, Omaha, Nebraska, USA.

出版信息

Clin Infect Dis. 2021 Sep 15;73(6):1128-1129. doi: 10.1093/cid/ciab248.

DOI:10.1093/cid/ciab248
PMID:33738504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8571562/
Abstract
摘要